Stomach, Esophageal and Duodenal Procedures DRG Reimbursement

DRG 328 addresses inpatient stomach, esophageal, and duodenal procedures without Complication or Comorbidity or Major Complication or Comorbidity, encompassing routine surgical interventions without added clinical complexity. This grouping matters for inpatient reimbursement because it assigns lower payment relative to cases with complications, influencing hospital payment and expected resource use under Medicare.

DRG 328 Overview

DRG 328 covers inpatient admissions for stomach, esophageal, and duodenal procedures without Complication or Comorbidity or Major Complication or Comorbidity. This category includes routine surgical interventions such as partial gastrectomy, repair of perforations, or simple bariatric-related procedures when no CC or MCC is present. It matters for Medicare payment because cases in this group typically receive lower relative weights and reimbursement than similar procedures with added complexity, affecting hospital revenue for straightforward surgical admissions. Payer classification under this Diagnosis-Related Group determines base payment adjustments and resource expectation for the hospitalization.

Perioperative enhanced recovery and complication reduction trials: These studies evaluate specific perioperative care bundles, minimally invasive versus open surgical approaches, and anesthetic/analgesic strategies for patients undergoing gastric, esophageal, or duodenal procedures without CC/MCC. The patient population typically includes elective surgical patients with primary benign conditions or early-stage malignancy who are otherwise without major comorbidities; investigators measure intraoperative metrics, postoperative complication rates (e.g., leaks, hemorrhage, pneumonia), length of stay, and readmissions. This research is relevant to providers and payers because reducing complications and shortening hospital stays directly impacts DRG resource use, reimbursement variability, and overall episode costs.
Comparative effectiveness studies of procedure selection and reconstruction techniques: These trials compare different operative techniques (for example, partial versus total gastrectomy approaches, different anastomotic methods, or variations in pyloric management) and their effects on functional outcomes such as nutritional status, dysphagia, and need for reintervention. The focus population is patients receiving stomach, esophageal, or duodenal procedures for benign disease or early neoplasia without significant comorbid conditions; outcomes include postoperative morbidity, long-term quality of life, and downstream utilization like outpatient nutrition support or procedures. Payers and clinicians use these data to inform which techniques yield the best balance of durable clinical benefit, lower postoperative resource consumption, and fewer costly complications within the DRG payment framework.
Post-discharge recovery and health services outcomes research: These studies examine transitional care interventions, home health utilization, and patient-reported recovery trajectories after discharge for low-complexity upper gastrointestinal surgeries, tracking readmission drivers, outpatient visits, and cost-of-care in the 30–90 day post-discharge window. The patient cohort includes patients classified to this DRG who are discharged home or to skilled services without major concurrent illnesses; analyses often link inpatient care processes to post-acute utilization and functional recovery markers. Findings are important for providers and payers to design discharge planning, allocate post-acute resources efficiently, and reduce avoidable readmissions that affect overall episode costs and quality metrics.

Perioperative enhanced recovery and complication reduction trials: These studies evaluate specific perioperative care bundles, minimally invasive versus open surgical approaches, and anesthetic/analgesic strategies for patients undergoing gastric, esophageal, or duodenal procedures without CC/MCC. The patient population typically includes elective surgical patients with primary benign conditions or early-stage malignancy who are otherwise without major comorbidities; investigators measure intraoperative metrics, postoperative complication rates (e.g., leaks, hemorrhage, pneumonia), length of stay, and readmissions. This research is relevant to providers and payers because reducing complications and shortening hospital stays directly impacts DRG resource use, reimbursement variability, and overall episode costs.
Comparative effectiveness studies of procedure selection and reconstruction techniques: These trials compare different operative techniques (for example, partial versus total gastrectomy approaches, different anastomotic methods, or variations in pyloric management) and their effects on functional outcomes such as nutritional status, dysphagia, and need for reintervention. The focus population is patients receiving stomach, esophageal, or duodenal procedures for benign disease or early neoplasia without significant comorbid conditions; outcomes include postoperative morbidity, long-term quality of life, and downstream utilization like outpatient nutrition support or procedures. Payers and clinicians use these data to inform which techniques yield the best balance of durable clinical benefit, lower postoperative resource consumption, and fewer costly complications within the DRG payment framework.
Post-discharge recovery and health services outcomes research: These studies examine transitional care interventions, home health utilization, and patient-reported recovery trajectories after discharge for low-complexity upper gastrointestinal surgeries, tracking readmission drivers, outpatient visits, and cost-of-care in the 30–90 day post-discharge window. The patient cohort includes patients classified to this DRG who are discharged home or to skilled services without major concurrent illnesses; analyses often link inpatient care processes to post-acute utilization and functional recovery markers. Findings are important for providers and payers to design discharge planning, allocate post-acute resources efficiently, and reduce avoidable readmissions that affect overall episode costs and quality metrics.

OpenPayer

Summary & Overview

Stomach, Esophageal and Duodenal Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 328 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes